FTD_GILENYA_NEUROSCIENCE

Drug Novartis Pharma AG
Total Payments
$15,710
Transactions
23
Doctors
10
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2020 $2,400 2 1
2019 $13,310 21 9

Payments by Nature

Nature of Payment Amount Transactions Share
Travel and Lodging $13,116 8 83.5%
Consulting Fee $2,400 2 15.3%
Food and Beverage $193.54 13 1.2%

Top Doctors Receiving Payments for FTD_GILENYA_NEUROSCIENCE

Doctor Specialty Location Total Records
, M.D Neurology San Francisco, CA $12,378 6
Amit Bar-Or Neurology Philadelphia, PA $2,400 2
, M.D Neurology New York, NY $738.88 2
, MD Neurology Aurora, CO $30.09 2
, MD Neurology Cleveland, OH $30.09 2
, M.D Internal Medicine San Francisco, CA $30.09 2
, M.D Neurology Houston, TX $30.09 2
, MD Neurology Boston, MA $30.09 2
, MD Neurology Saint Louis, MO $30.09 2
, M.D Neurology New York, NY $13.00 1

About FTD_GILENYA_NEUROSCIENCE

FTD_GILENYA_NEUROSCIENCE is a drug associated with $15,710 in payments to 10 healthcare providers, recorded across 23 transactions in the CMS Open Payments database. The primary manufacturer is Novartis Pharma AG.

Payment data is available from 2019 to 2020. In 2020, $2,400 was paid across 2 transactions to 1 doctors.

The most common payment nature for FTD_GILENYA_NEUROSCIENCE is "Travel and Lodging" ($13,116, 83.5% of total).